Evidence mapPaperPMID 40014670Full record

GuidelineCirculation2025

2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Sunil V Rao, Michelle L O'Donoghue, Marc Ruel, Tanveer Rab, Jaqueline E Tamis-Holland, John H Alexander, Usman Baber, Heather Baker, Mauricio G Cohen, Mercedes Cruz-Ruiz and 20 more

Erratum issued 8 registry-linked trialsAbstract readPractice GuidelineReview
PubMed Publisher
In one paragraph

Guideline in Circulation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It reports registered trial NCT07008794. Cited by 526 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
526citing papers in PubMed, 7 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07008794 completed

Studying the Effect of Genetic Variation on Efficacy and Safety of Lipid-Lowering Drugs in Patients With Cardiovascular Diseases

Ran2022Enrolled200Registered outcomes2Posted comparisons0ConditionsAcute Coronary SyndromesArmsAtorvastatin 40 mg
PMID 37740496other papers from this trial
Open the trial in the graph
NCT07465926 completed

Associations of Early Add-On GLP-1 Receptor Agonist and SGLT2 Inhibitor Therapy With Mortality and Kidney Outcomes in Adults With Obesity and Type 2 Diabetes Across Cardiovascular-Kidney-Metabolic Stages 2-3: A Target-Trial Emulation

Ran2017Enrolled451,036Registered outcomes12Posted comparisons0ConditionsCardiovascular Disease Risk Factor, Cardiovascular-kidney-metabolic Syndrome, Kidney Disease, Obesity & OverweightArmsGLP-1 receptor agonist, SGLT2 inhibitor
Open the trial in the graph
NCT07175259 not yet recruitingnot on this map

Relation of Total Ischemic Time to Repolarization Indices and Their Impact on Outcomes Among STEMI Patients Undergoing Primary PCI

TypeobservationalSponsorAssiut UniversityRan2025 to 2026Enrolled500ConditionsST Elevation (STEMI) Myocardial Infarction of Other Sites, Repolarization Indices, Total Ischemic Time, Primary Percutaneous Coronary InterventionArmsEchocardiography
NCT07267884 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Evaluation of the Effectiveness and Safety of Intra-Aortic Balloon Pump Insertion in Patients With Ventricular Septal Defect Following Myocardial Infarction During SCAI SHOCK Stage B: A Multicenter, Randomized, Open-Label, Parallel Controlled Study

TypeinterventionalSponsorQilu Hospital of Shandong UniversityRan2026 to 2029Enrolled100ConditionsAcute Myocardial Infarction (AMI), Ventricular Septal Defects (VSD)ArmsInsertion of IABP in SCAI SHOCK stage B
NCT07290699 phase4not yet recruitingnot on this mapstarted 2026, after this paper: background citation

INtensive Cholesterol-Lowering With recatIcimab combiNation in Emergency PCI for Acute Myocardial Infarction: A Randomized Controlled Trial

TypeinterventionalSponsorSecond Affiliated Hospital of Nanchang UniversityRan2026 to 2028Enrolled2,442ConditionsSTEMI - ST Elevation Myocardial Infarction, NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)ArmsRecaticimab
NCT07374718 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Optimization and Verification of Quality Control Indicators for Coronary Revascularization Based on Antiplatelet Therapy: Safety and Efficacy of De-escalation Dual Antiplatelet Therapy in Moderate-to-high Ischemic Risk and High Bleeding Risk ACS Patients After BioFreedom™ Drug-Coated Coronary Stenting

TypeinterventionalSponsorShenyang Northern HospitalRan2026 to 2029Enrolled468ConditionsAcute Coronary Syndrome (ACS), High Bleeding Risk(HBR), Coronary Artery Disease (CAD)ArmsIVUS-guided BioFreedomTM Drug-Coated Stent Implantation + 1-Month DAPT Followed by 11-Month P2Y12 Inhibitor Monotherapy, Angiography-guided Conventional Drug-Eluting Stent Implantation + 12-Month Dual Antiplatelet Therapy (Aspirin + P2Y12 Inhibitor)
NCT07551700 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Efficacy of Thrombus Aspiration in Patients With Acute ST-Segment Elevation Myocardial Infarction: A Prospective, Multicenter, Randomized, Controlled, Single-Blind Clinical Trial (TRAP-MI)

TypeinterventionalSponsorFirst Affiliated Hospital Xi'an Jiaotong UniversityRan2026 to 2028Enrolled6,760ConditionsST-segment Elevation Myocardial Infarction (STEMI)ArmsManual Thrombus Aspiration, Primary Percutaneous Coronary Intervention (PPCI)
NCT07562932 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Assessing Catecholamine Treatment Initiation Options: Norepinephrine vs Dopamine for Cardiogenic Shock

TypeinterventionalSponsorChonnam National University HospitalRan2026 to 2032Enrolled512ConditionsCardiogenic ShockArmsNorepinephrine, Dopamine Agent
3 · Its place in the literature

Who cites it

526 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Depression, health anxiety, and five-year mortality after ST-elevation myocardial infarction: the SEMI-CI cohort.International journal of cardiology. Cardiovascular risk and prevention · 2026
    Article
  14. Article
  15. Review
  16. Review
  17. Short Versus Extended Duration of Triple Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients Requiring Oral Anticoagulation: A Retrospective Single-Center Study.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026
    Observational
  18. Article
  19. Article
  20. Observational

466 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors.

Sunil V Rao
Michelle L O'Donoghue
Marc Ruel
Tanveer RabACC/AHA Joint Committee on Clinical Practice Guidelines liaison.
Jaqueline E Tamis-HollandACC/AHA Joint Committee on Clinical Practice Guidelines liaison.
John H Alexander
Usman Baber
Heather BakerLay stakeholder/patient representative.
Mauricio G Cohen
Mercedes Cruz-RuizLay stakeholder/patient representative.
Leslie L Davis
James A de Lemos
Tracy A DeWald
Islam Y Elgendy
Dmitriy N FeldmanSociety for Cardiovascular Angiography and Interventions representative.
Abhinav Goyal
Ijeoma Isiadinso
Venu Menon
David A Morrow
Debabrata Mukherjee
Elke Platz
Susan B PromesAmerican College of Emergency Physicians representative.
Sigrid Sandner
Yader Sandoval
Rachel SchunderACC/AHA joint staff representative.
Binita Shah
Jason P StopyraNational Association of EMS Physicians representative.
Amy W TalbotACC/AHA joint staff representative.
Pam R Taub
Marlene S WilliamsACC/AHA Joint Committee on Performance Measures representative.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe "2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes" incorporates new evidence since the "2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction" and the corresponding "2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes" and the "2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction." The "2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes" and the "2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization" retire and replace, respectively, the "2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease."

methodsA comprehensive literature search was conducted from July 2023 to April 2024. Clinical studies, systematic reviews and meta-analyses, and other evidence conducted on human participants were identified that were published in English from MEDLINE (through PubMed), EMBASE, the Cochrane Library, Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. STRUCTURE: Many recommendations from previously published guidelines have been updated with new evidence, and new recommendations have been created when supported by published data.

Indexed as

Acute Coronary SyndromeCardiologyPercutaneous Coronary InterventionPlatelet Aggregation InhibitorsAmerican Heart AssociationDisease ManagementHumansST Elevation Myocardial InfarctionUnited StatesPlatelet Aggregation Inhibitorsacute coronary syndrome(s)AHA Scientific Statementsangina, unstableanticoagulantsaspirinatrial fibrillationcardiovascular diseasescoronary artery diseasecoronary syndromeemergency medical servicesEMSfibrinolytic agentshemorrhagemajor adverse cardiovascular eventsmorphinemyocardial infarctionnon–ST-segment elevation myocardial infarctionpercutaneous coronary interventionprehospitalrevascularizationriskST-segment elevation myocardial infarctiontime factorstreatment outcome

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

and 2 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.